Information  X 
Enter a valid email address

Broker Forecast - RBC Capital Markets issues a broker note on Clinigen Group

By BFN News | 02:20 PM | Tuesday 14 July, 2020


RBC Capital Markets today reaffirms its outperform investment rating on Clinigen Group (LON:CLIN) and cut its price target to 1300p (from 1500p). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

a d v e r t i s e m e n t